Polymeric carriers for oral uptake of microparticulates

Delivery of vaccine antigens by the oral route is plagued with challenges. Much of the research has focused on the development of microparticles as antigen carriers to the gastrointestinal (GIT) mucosa. Polymers, either natural or synthetic, have been the class of compounds most often investigated for their ability to form microparticles containing antigen. A great deal of research has been performed using model microparticles composed of polystyrene. From this work it has become clear that microparticles are taken up and translocated across the GIT epithelium. Antigen carrying microparticles generated from both hydrophobic and hydrophilic polymers are able to induce significant immune responses after oral immunization. Although very little systematic work on the effects of the physicochemical properties of the polymer composing the microparticles has been done, enough is known to conclude that the surface of the polymeric microparticle can be decisive in determining the overall uptake of the microparticles. Charge and the hydrophobic/hydrophilic balance of the polymer are important physicochemical characteristics that determine the value of the polymer as a microparticulate carrier. This review examines the properties of polymeric matrices that make them viable candidates as oral vaccine delivery vehicles.     

Protein release from polyphosphazene matrices

Polyphosphazenes have been exploited as carriers for protein delivery due to versatility of molecular structures and sophisticated spectrum of chemical and physical properties. Ease of structural manipulations for this class of organometallic polymers allows efficient control over physico-chemical parameters of polyphosphazenes including their biodegradability and matrix permeability. Some polyphosphazenes offer additional advantages as protein delivery vehicles since microencapsulation of substrates in these systems can be achieved under remarkably mild physiological conditions. Because of these properties polyphosphazenes have tremendous potential as matrices for protein release as shown by studies both in vitro and in vivo.     

Ultrastructural morphometry in the diagnosis of Sézary syndrome

Blood specimens from 87 patients and control subjects were prepared for electron microscopy and subjected to ultrastructural morphometric evaluation by using a computerized planimeter. A statistical comparison of means indicated that patients with Sézary syndrome could be distinguished from normal subjects and patients with reactive lymphocytosis, by using mean nuclear perimeter and form factor values. The lymphocytic nuclei from patients with infectious mononucleosis were more lobated on visual inspection than those from normal subjects; the difference in mean form factor values was statistically significant. The simple histogram method was most discriminatory and distinguished patients with Sézary syndrome from patients with other types of lymphoid leukemias and reactive lymphocytosis, including infectious mononucleosis. The histogram method could not, however, distinguish patients with Sézary syndrome from patients with T-cell chronic lymphocytic leukemia and Japanese T-cell leukemia. The use of bivariate graphic displays (plotting nuclear size and shape measurements) placed the lymphoid cells of the various types of lymphoproliferative disorders into distinct morphometric domains. Computerized morphometric techniques may, therefore, be of greater value when the range of possible diagnoses is large.     

Interpretation of serum total calcium: effects of adjustment for albumin concentration on frequency of abnormal values and on detection of change in the individual.

Serum total calcium was measured in 1693 patients during a four-month period. We examined the effects of adjustment for albumin concentration on the interpretation of single measurements of serum total calcium and on the variation of series of measurements in individual patients. Markedly abnormal total calcium concentrations--2.75 mmol/l (11.0 mg/100 ml) or more, or 2.00 mmol/l (8.0 mg/100 ml) or less--were found in 115 patients, but only 24 (21%) remained markedly abnormal after adjustment for albumin. Three patients, two with malignant disease and one with primary hyperparathyroidism, had significant hypercalcaemia which was masked by hypoalbuminaemia. The serum total calcium measured on a subsequent occasion had changed 0.15 mmol/l (0.6 mg/100 ml) or more in 60 patients, but after adjustment for albumin this number was reduced to 27 (45%). The within-person standard deviation for serum total calcium was calculated in 26 patients with normal mean adjusted calcium concentrations who had had six or more sequential measurements. The mean standard deviation was 0.148 mmol/1 (0.59 mg/100 ml) and, after adjustment for albumin, this was reduced to 0.100 mmol/1 (0.40 mg/100 ml). We conclude that adjustment of serum total calcium concentration for albumin is essential to detect abnormal values and to assess changes in a value.     

Bovine coronavirus antigen in the host cell plasmalemma

Expression of bovine coronavirus (BCV) antigen in the plasmalemma of epithelioid human rectal tumor (HRT-18) and fibroblastic bovine fetal spleen (BFS) cell lines was traced by immunofluorescence and immunoelectron microscopy facilitated by colloidal gold. Cytoplasmic fluorescence was first observed at 12 hr postinfection (h.p.i) in infected HRT-18 cultures. This fluorescence coincided with the appearance of cell surface antigen reacting with colloidal gold-labeled antibodies to BCV antigens. At 24 h.p.i the amount of viral antigens at the surface of HRT-18 had increased, although cytoplasmic fluorescence remained constant. Infected BFS cells but not HRT-18 cells formed polykaryons when incubated in the presence of trypsin. One viral antigen in the plasma membrane of BFS cells was thus identified as the S glycoprotein with a fusion domain. In contrast to HRT-18 cells, the overall amount of BCV antigens at the surface of BFS cells remained constant after the onset of fusion. Analysis of the labeling characteristics established that the gold-marked-sites represented de novo expression of BCV antigen in the plasma membrane of infected cells.     

Synthetic oligodeoxyribonucleotide probes to detect Kanagawa phenomenon-positive Vibrio parahaemolyticus.

Synthetic oligodeoxyribonucleotide probes were used in the colony hybridization test to examine the association between the Kanagawa phenomenon (KP) and the thermostable direct hemolysin gene (tdh) of Vibrio parahaemolyticus. Representative V. parahaemolyticus strains with a variety of KP reactions and 17 other Vibrio species were examined for homology with four synthetic oligodeoxyribonucleotide probes (19 to 21 bases long) representing different regions of the tdh structural gene. Under stringent conditions, two of the probes were capable of distinguishing KP-positive V. parahaemolyticus from KP-negative or KP weak-positive V. parahaemolyticus which possesses mutated tdh genes. Vibrio hollisae strains hybridized with all four probes under reduced stringency, suggesting that they have tdh-related genes which are homologous but not identical to the tdh gene in all the regions examined. The results suggest that the colony hybridization test with the synthetic oligonucleotide probes is more suitable for the definitive determination of KP-positive strains than the hybridization with the larger gene probe or immunological assays.     

Testicular fibrosis and cardiomegaly in Shwachman's syndrome

Shwachman's syndrome is an uncommon disorder; its principal manifestations are pancreatic and hematopoietic insufficiency. We report here a case of Shwachman's syndrome with autopsy findings of cardiomegaly (anticipated from clinical observations) and unexpected testicular fibrosis, both examined by electron microscopy.     

Post‐mastectomy Radiotherapy for pT3N0 Breast Cancers: A Retrospective,Multi‐Institution Review

The role of post‐mastectomy radiotherapy for pT3N0 breast cancers remains undefined. The purpose of this study was to report institutional outcomes for women with pT3N0 breast cancers treated with and without post‐mastectomy radiotherapy. We collected data from two large tumor registries on pT3N0 breast cancers diagnosed between 1985 and 2014. Kaplan–Meier estimates were used to analyze freedom from local‐regional recurrence (FFLR), relapse free survival, and overall survival. This analysis identified 93 women with pT3N0 breast cancers. Of these, 53 received post‐mastectomy radiotherapy and 40 did not. Median follow‐up was 6.2 years and 5.3 years in the non‐post‐mastectomy radiotherapy and post‐mastectomy radiotherapy cohorts, respectively. Women not undergoing post‐mastectomy radiotherapy were more likely to be diagnosed in the 1980s and 1990s and were less likely to receive systemic therapies than women receiving post‐mastectomy radiotherapy (p < 0.05). There was a trend toward increased FFLR in the women receiving post‐mastectomy radiotherapy (p = 0.15). FFLR in the post‐mastectomy radiotherapy cohort was 98% at both 5 and 10 years. For women not receiving post‐mastectomy radiotherapy, FFLR was 88% at both 5 and 10 years. Women not receiving post‐mastectomy radiotherapy in our study had an isolated local‐regional failure rate of 12% at 10 years, despite receiving inferior systemic treatment by current standards. Local‐regional control after post‐mastectomy radiotherapy for pT3N0 breast cancers was excellent. Further research is needed to define post‐mastectomy radiotherapy indications for this patient population when receiving chemotherapy and endocrine therapy in line with current guidelines.